Table 1.
Baseline demographics and clinical characteristics.
| Variable | Category | All (n=340) | Control (n=176) | Intervention (n=164) | P a |
| Age, years, mean (SD) |
|
55.0 (8.9) | 54.8 (9.1) | 55.1 (8.8) | .77 |
| Female, n (%) |
|
107 (31.5) | 54 (30.7) | 53 (32.2) | .75 |
| Race/ethnicity, n (%) b | .38 | ||||
|
|
White | 204 (60.0) | 104 (59.1) | 100 (61.0) |
|
|
|
Black | 7 (2.1) | 1 (0.6) | 6 (3.7) |
|
|
|
Asian | 63 (18.5) | 36 (20.4) | 27 (16.5) |
|
|
|
Hispanic | 16 (4.7) | 9 (5.1) | 7 (4.3) |
|
|
|
Other | 8 (2.3) | 5 (2.8) | 3 (1.8) |
|
|
|
Not reported | 42 (12.4) | 21 (11.9) | 21 (12.8) |
|
| Blood pressure, mmHg, mean (SD) | |||||
|
|
Systolic | 130.4 (14.7) | 130.4 (14.5) | 130.4 (15.0) | .99 |
|
|
Diastolic | 82.3 (8.4) | 82.6 (8.6) | 82.0 (8.1) | .45 |
| Weight, lbs, mean (SD) |
|
204.8 (34.8) | 205.6 (36.5) | 203.9 (32.9) | .64 |
| BMI, kg/m2, mean (SD) |
|
31.1 (4.3) | 31.2 (4.3) | 31.1 (4.4) | .86 |
| Waist circumference, cm, mean (SD) |
|
102.8 (10.8) | 103.1 (11.2) | 102.5 (10.4) | .59 |
| Glucose, mg/dL, mean (SD) |
|
109.9 (8.4) | 109.0 (8.3) | 110.2 (8.6) | .52 |
| HbA1c, %, mean (SD) |
|
5.6 (0.3) | 5.6 (0.3) | 5.6 (0.3) | .94 |
| Total cholesterol, mg/dL, mean (SD) |
|
191.5 (31.7) | 191.9 (33.0) | 191.2 (30.2) | .83 |
| LDL cholesterol, mg/dLc, mean (SD) |
|
116.0 (27.6) | 116.5 (27.9) | 115.5 (27.3) | .72 |
| HDL cholesterol, mg/dLc, mean (SD) |
|
47.3 (14.0) | 46.5 (13.0) | 47.8 (14.5) | .40 |
| Triglycerides, mg/dLc, mean (SD) |
|
144.6 (73.7) | 148.2 (68.8) | 139.4 (67.3) | .24 |
aSignificance of difference between intervention and control.
bNative American/Alaskan, Native Hawaiian/Pacific Islander, reported as multiple races or “other”. Ethnicity from EHR.
cFor LDL: Control, n=172, Intervention, n=161; for HDL: Control, n=176, Intervention, n=162; for triglycerides: Control, n=174, Intervention, n=162; for waist circumference: Control, n=175, Intervention, n=163.